Sexually transmitted disease from the urologist's point of view

1. Toriová V. Mykoplazmatické a chlamydiové respirační infekce ve vztahu k ATB léčbě. Přednáška.

2. CMO's Expert Advisory Group on Chlamyda trachomatis in UK, 2004.

3. Chlamydia screening among sexually active young female enrolles of health plans - United States, 1999-2001 MWR. Morb Mortal Wkly Rep 2004; 53(42): 983-985.

4. Westrom L. Incidence, prevalence, and trend of acute pelvic inflammatory disease and its consequences in industrialized Countries. Am J Obstet Gynecol 1980; 138: 880-892.

5. California Chlamydia Action Coalition. Chlamydia Screening and Treatment Practice Guidelines 2002.

6. Grella M. Chlamydial infections. eMedicine Journal 2001; 2(10).

7. Arzouni JP, Bouilloux JP, de Mouy D, Bicart-See A, Charbit C, Doeschler T, Fleutiaux S, Galinier JL, Gontier P, Lacharme H, Larribet G, Berges JL, Lepargneur JP, Armengaud A. Genital infections in women, in community practice. Comparison of two studies, 1987 and 2002. Med Mal Infect 2004; 34(2): 92-96.

8. Lambiase MC, Vaughan TK. eMedicine Journal 2002; 3(1).

9. Owen MK, Clenney TL. Management of vaginitis. Am Fam Physician 2004;70(11): 2125-2132.

10. Pirotta M, Gunn J, Chondros P et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ 2004; 329: 548-551.

11. Hlášená onemocnění pohlavními nemocemi v ČR v roce 2000, aktuální informace č. 38/2001, ÚZIS ČR.

12. Hlášená onemocnění pohlavními nemocemi v ČR v roce 1999, aktuální informace č. 22/2000, ÚZIS ČR.

14. Resl V. Doporučené postupy pro praktické lékaře, grant a/004/233, Sexuálně přenosné nemoci II, 2002.

15. Byron EB. STDs, Progress! International Congress of Sexually Transmitted Infections: 2nd Joint Meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR) and the International Union against Sexually Transmitted Infections (IUSTI) June 24-27, 2000, Berlin.

16. Diaz-Mitoma F, Sibbald G, Shafran SD, Boon R, Saltzman RL. Oral Famciclovir for the Suppression of Recurrent Genital HerpesTrial: A Randomized Controlled for the Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998; 280: 887-892.

17. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection Review. CMAJ 2001; 164(7); 1017-1025.

18. Brett C. Mellinger, Human Papillomavirus in the Male: An Overview, AUA Lesson 13 Volume 8, 1994.

19. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3-8.

20. Franco EL, Villa LL, Richardson H, Rohan T, Ferenczy A. Epidemiology of cervical human papillomavirus infection. In: Franco EL, Monsonégo J (eds). New developments in cervical cancer screening and prevention. Oxford: Blackwell Science 1997: 14-22.

21. National Institutes of Health Consensus Confe­ren­ce on Cervical Cancer. Bethesda, Maryland, April 1-3, 1996. J Natl Cancer Inst Monogr 1996; 21: 1-148.

22. Munoz N, Bosch FX. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull Pan Am Health Organ 1996; 30: 362-377.

23. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-964.

24. Dupin N. Genital warts. Clin Dermatol 2004; 22(6): 481-486.

25. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: International Agency for Research on Cancer, World Health Organization 1995; 64. vol.

26. Shepherd J, Weston R, Peersman G, Napuli IZ. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer (Cochrane Review). In: The Cochrane Library. Oxford: Update software 2000; 1. vol.

27. Ramirez JE, Ramos DM, Clayton L, Kanowitz S, Moscicki AB. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health 1997; 6: 113-121.

28. Franco EL, Syrjänen K, De Wolf C, Patnick J, Ferenczy A, McGoogan E et al. Meeting report: new developments in cervical cancer screening and prevention. Cancer Epidemiol Biomarkers Prev 1996; 5: 853-856.

29. Cardamakis E, Relakis K, Ginopoulos P, Korantzis A, Metalinos K, Stathopoulos E, Papathanasiou Z, Michopoulos J, Mantouvalos H, Kotoulas IG, Tzingounis V. Treatment of penile intraepithelial neoplasia (PIN) with interferon alpha-2a, CO2 laser (vaporization) and 5-fluorouracil 5% (5-FU). Eur J Gynaecol Oncol. 1997; 18(5): 410-413.

30. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G. GlaxoSmithKline HPV Vaccine Study Group.Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364(9447):1757-1765.

31. Garnett GP. Role of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted, Disease. J Infect Dis 2005; 191(Suppl 1): S97-S106.

32. Taira AV. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis 2004; 10(11): 1915-1923.

33. http://hivinsite.ucsf.edu

34. Treat 3 by 5: Scaling up antiretroviral therapy in ressource limited settings: treatment guidelaines for a public health approach, 2003 revision of World Health Organization, Geneve 2004.

35. Hlášená onemocnění pohlavními nemocemi v ČR v roce 2000, aktuální informace 38/2001 ÚZIS.

36. Frassetto L, Schoenfeld PY, Humphreys MI. Increasing incidence of human immunodeficiency vi­ru­se associated nephropathy at San Francisco Gene­ral Hospital. Amer J Kidney Dis 1991; 18: 655-659.

37. Vitting KE, Gardenswartz MI-I, Zabetakis PM et al. Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA 1990; 263: 973-978.

38. Guerra I, Kimmel PL. Hypokalemic adrenal crisis in a patient with AIDS. South Med J 1991; 84: 1265-1267.

39. Comiter S, Glasser J, Al-Askari S. Ureteral obstruction in a patient with Burkitt's lymphoma and AIDS. Urology 1992; 39: 277-280.

40. Mohler JL, Jarow JP, Marshall FF. Unusual urological presentations of acquired immune dificiency syndrome: Large cell lymphoma. J Urol 1987; 138: 627-629.

41. Zaleski C, Burke G, Nery J et al. Risk of AIDS (HIV) transmission in 581 renal transplants. Transplant Proc 1993; 25: 1483-1484.

42. Leport C, Rousseau F, Perronne C et al. Bacterial prostatitis in patiens infected with the human immunodeficiency virus. J Ural 1989; 141: 334-336.

43. Zighelboim J, Goldfarb RA, Mody D et al. Prostatic abscess due to Histoplasma Capsulatum in a patient with the acquired immunodeficiency syndrome. I Ural 1992; 1473: 166-168.

44. Adams JR, Mata JA, Culkin DJ et al. Acquired immunodeficiency syndrome manifesting as prostatic nodule secondary to cryptococcal infection. Urology 1992; 39: 289-291.

45. Mamo GJ, River MA, Jacobs SC. Cryptococcal prostatic abscess associated with the acquired immunodeficiency syndrome. J Ural 1992; 148: 889-890.

46. Lowe FC, LattimerDG, Metroka CE. Kaposi´s sarcina of the penis in patiens with AIDS. J Urology 1989; 142: 1475-1477.

47. Vapnem JM, Quivey JM, Carroll PR. AIDS - related Kaposi´s sarcoma of the male genitalia: management with radiation therapy. J Urol 1991; 1145: 333-336.

48. Safai B, Schwartz JJ. Kaposi's sarcoma and the acquired immunodeficiency syndrome. In Devita VT Jr, Hellman S, and Rosenberg SA (eds). AIDS: Etiology, Diagnosis, Treatment and Prevention. 3rd ed Philadelphia: JB Lippincott 1992: 209-223.

49. Kwan DJ, Lowe FC. Acquired immunodeficiency syndrome A venereal disease. Ural Clin North Am 1992; 19: 13-24.

50. Leibovitch I, Goldwasser B. The spectrum of acquired immune deficienty syndrome-associated testicular disorders. Urology 1994; 443: 818-824.

51. Wilson TW, Frenkel E, Vuitch F et al. Testicular tumors in men with human immunodeficiency virus. I Urol 1992; 147: 1038-1040.

52. Lopez AE, Latiff AG, Ciancio G et al. Lymphoma of urethra in patient with acquired immune deficiency syndrome. Urology 1993; 42: 596-598.

53. Snider WD, Simpson DM, Nielsen S et al. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neural 1983; 14: 403-418.

54. Staňková M, Rozsypal H. Doporučené postupy pro praktické lékaře. Reg. č.o/020/249, HIV infekce, 2002.